The pharmaceutical manufacturing company of Malaysia said it has filed lawsuits against the pharmaceutical manufacturing manufacturer of Indonesia, accusing it of using unsafe antibiotics in production.
Malaysia Pharma, the country’s largest pharmaceutical manufacturing corporation, said it filed the suit against the Indonesian pharmaceutical manufacturing giant, Bausak Pharmaceuticals, on Friday, saying the company was responsible for “inappropriate and improper use of antibiotics” in its production and sales.
The company’s suit also alleged the company “continues to use improper and inappropriate antibiotics in its drug manufacturing operations, including in the manufacturing of antibiotics for its own product, which has been the subject of numerous and repeated health violations by Bausack Pharmaceuticals.”
The suit said BausAK “has not complied with the standards required by the manufacturer” and is not complying with the requirements of the Malaysian Food Safety and Quality Act.
Malay Prime Minister Datuk Seri Najib Razak said Malaysia would investigate the allegations.
Malayan pharmaceutical companies, including the countrys largest pharmaceutical manufacturer, have faced criticism from the government and from patients for using inappropriate antibiotics and for failing to control the spread of resistant bacteria.
Malain Drug and Equipment Co. Ltd., the largest pharmaceutical maker in the country, is the largest producer of antibiotics in the world, with about 1,300 drugs in its portfolio.
Malian drug makers have also been accused of using cheap antibiotics in countries such as Afghanistan, Bangladesh, China and India.